GLP-1 and Birth Control: Semaglutide and Oral Contraceptives

The key concern

You are considering starting a GLP-1 medication and you take oral contraceptive pills. You want to know: will the medication affect your birth control?

The short answer is that GLP-1 medications can theoretically affect how quickly your body absorbs oral contraceptives, but the actual clinical impact is small. The most important action you can take is to talk to your provider before starting treatment and follow their guidance on timing.

How GLP-1 affects medication absorption

GLP-1 receptor agonist medications work by slowing gastric emptying. This means the stomach releases food and liquids into the small intestine more slowly than normal. This is how the medication reduces appetite and controls blood sugar.

But there is a practical consequence: if your stomach is emptying more slowly, medications that are absorbed in the gastrointestinal tract are also absorbed more slowly. This creates the potential for altered absorption of oral medications, including oral contraceptive pills.

For oral contraceptives specifically, the concern is absorption of the hormonal components (ethinyl estradiol and levonorgestrel, or other formulations). If absorption is delayed or reduced, the effectiveness of the contraceptive could theoretically be compromised.

What the research actually shows

The FDA evaluated this interaction when reviewing semaglutide for approval. In pharmacokinetic studies examining the interaction between semaglutide and oral contraceptives, the results were reassuring^[1]: semaglutide did not meaningfully reduce the bioavailability (the amount your body actually absorbs) of ethinyl estradiol or levonorgestrel.

In other words, in the studies that were done, the oral contraceptive pill was absorbed at approximately the same level with semaglutide as without it.

Despite this relatively limited interaction data, the FDA-approved label for branded semaglutide^[1] still recommends a practical precaution: take your oral contraceptive at least 1 hour before your semaglutide injection, or 4 hours after, for the oral semaglutide formulation.

Why such a cautious recommendation if the studies showed minimal interaction? Because the concern matters most during the early weeks of treatment when your body is adjusting to the medication and gastric emptying changes are being established. And because the cost of inadequate contraceptive coverage for someone who wants to prevent pregnancy is high enough to warrant the extra precaution.

Oral contraceptives vs. other birth control methods

This interaction is specific to oral contraceptive pills. Other birth control methods are not affected by GLP-1 medications because they do not rely on gastrointestinal absorption.

Methods NOT affected by GLP-1:

• Hormonal intrauterine devices (IUDs like Mirena, Kyleena, Skyla)
• Contraceptive implants (Nexplanon)
• Birth control injections (Depo-Provera)
• Hormonal patches (Ortho Evra)
• Vaginal rings (NuvaRing)
• Barrier methods (condoms, diaphragm)
• Copper IUDs

If you are concerned about the interaction with oral contraceptives, or if you are planning a medication transition, these alternative methods work regardless of GLP-1 use.

Practical guidance: what to do if you take both

Before starting GLP-1 treatment:

Tell your provider. During your intake consultation, mention your current birth control method. Your provider will review whether any timing adjustments are needed and discuss your comfort level with backup precautions.

Consider timing. If you continue taking oral contraceptive pills while on GLP-1 medication, take your pill at least 1 hour before your GLP-1 injection day (if you receive a weekly injection). For oral semaglutide formulations, follow the timing guidance on your prescription label.

Use backup contraception in the early weeks. Some providers recommend using additional contraception (such as condoms) during the first 4-8 weeks of GLP-1 treatment. This is not required for everyone, but it is an extra precaution while your body is adjusting to the medication and gastric emptying changes are most pronounced.

Watch for irregular bleeding. If you experience breakthrough bleeding, spotting, or other changes to your usual menstrual pattern after starting GLP-1, contact your provider. It may be a sign of reduced pill absorption, or it could be due to other factors including the medication’s effects on the GI tract. Your provider can help determine the cause and adjust your plan if needed.

Discuss your timeline if planning pregnancy. If you are thinking about becoming pregnant in the near future, discuss the timing with your provider. GLP-1 medications are not recommended during pregnancy, so you will need to discontinue treatment before attempting conception.

A note for perimenopausal women

Many women in their 40s and early 50s are starting GLP-1 medications while navigating the perimenopause transition. Some in this age group may not be using hormonal birth control at all, either because they have already entered menopause or because they prefer non-hormonal methods.

If you have had your final menstrual period, are using a non-hormonal contraceptive method, or are not using any contraception, the GLP-1 and oral contraceptive interaction is not clinically relevant to you.

However, if you are in perimenopause (where periods may be irregular but still occurring) and you do use oral contraceptives, the guidance above applies.

Pregnancy and GLP-1 medications

GLP-1 medications should be discontinued if you are pregnant or planning to become pregnant^[1].

If you are planning pregnancy: Discuss your timeline with your provider. The standard recommendation is to stop GLP-1 medication at least 2 months before attempting conception. This allows the medication to clear from your system before pregnancy.

If you become pregnant while on GLP-1 therapy: Contact your provider immediately. Your provider will help you discontinue the medication safely and discuss next steps.

If you are not sure about your pregnancy status: If you miss a period or suspect you may be pregnant while on GLP-1 medication, use a home pregnancy test and contact your provider. Do not wait to see if your period returns.

GLP-1 medications have not been studied in pregnant people, and animal data raised some concerns about fetal development^[1]. Pregnancy with GLP-1 in your system is not safe and should be addressed promptly.

The bottom line

GLP-1 medications slow gastric emptying, which can theoretically affect oral contraceptive absorption. But the actual clinical interaction is small, and practical timing adjustments can minimize any risk.

If you take oral contraceptive pills:

• Tell your provider before starting GLP-1 treatment
• Take your pill at least 1 hour before your injection if possible
• Consider backup contraception during the first few weeks of treatment
• Watch for irregular bleeding and report it to your provider
• Discuss your birth control method and pregnancy timeline during your intake consultation

Non-oral contraceptive methods (IUD, implant, patch, ring, injection) are not affected by GLP-1 medications and remain fully effective.

If you have questions about your specific birth control method or GLP-1 medication, your provider can give you personalized guidance based on your health history.

Citations

[1] FDA. “Prescribing Information for semaglutide for type 2 diabetes.” FDA-approved product labeling. 2022. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215256s000lbl.pdf